ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 166237 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 166237; 2) Community: the network communities that were significantly associated with the response to NSC 166237; 3) Molecule: the relationships between components within communities and NSC 166237; 4) MDR: the compounds that were significantly associated with the NSC 166237.

NSC Compound Enrichment Correlation
NSC 669793 Null 0.000532830026959993 -0.054101318
NSC 737672 9-Acetamido-6-(3-bromopropyl)-5,6-dihydro-3-nitro-5,11-dioxo -11H-indeno[1,2-c]isoquinoline 0.000532830026959993 0.47760701
NSC 673095 Null 0.000573863872925591 0.5340281
NSC 681644 Camptothecin Derivative 0.000573863872925591 0.57523534
NSC 758450 Mitoxantrone hydrochloride (USAN) 0.000573863872925591 0.57311517
NSC 666870 Null 0.000602374785885774 0.52550492
NSC 88971 Null 0.000602374785885774 0.25988762
NSC 659687 6H-Pyrido[4,3-b]carbazole-1-carboxamide, 9-hydroxy- 5,6-dimethyl-N-[2-(dimethylamino)ethyl]-, dihydrochloride 0.000610795106687072 0.51004531
NSC 734296 6-(3-Bromopropyl)-5,6-dihydro-8,9-dimethoxy-3-nitro-5,11-dio xo-11H-indeno[1,2-c]isoquinoline 0.000610795106687072 0.54335955
NSC 681642 Camptothecin Derivative 0.000967118311825465 0.58283529
Total:64  Current:3    [First] [Prev] [Next] [Last]